Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Pharmaceuticals6.36%+0.62 ppBiotechnology3.09%+0.60 ppManaged Health Care2.45%+0.51 ppHealth Care Equipment3.59%+0.40 ppLife Sciences Tools & Services2.01%+0.20 ppHealth Care Services1.07%+0.14 ppHealth Care Supplies0.12%-0.05 ppHealth Care Facilities0.21%-0.03 ppHealth Care Distributors0.37%+0.02 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
3.09%
Industry change · 12M
+0.60 pp
Biotechnology · contribution
+0.599 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Apr 2020 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| Amgen → AMGN | United States | $141.1bn | 0.790% | +0.156 pp | +0.168 pp | +37.4% | Yes |
| Gilead Sciences → GILD | United States | $106.1bn | 0.594% | +0.200 pp | +0.132 pp | +34.1% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $65.1bn | 0.364% | +0.076 pp | +0.124 pp | +48.7% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $49.4bn | 0.277% | +0.120 pp | +0.097 pp | +53.3% | Yes |
| AbbVie → ABBV | United States | $121.6bn | 0.680% | +0.089 pp | +0.028 pp | +9.7% | Yes |
| Incyte → INCY | United States | $21.2bn | 0.118% | +0.041 pp | +0.027 pp | +27.2% | Yes |
| Biogen → BIIB | United States | $48.4bn | 0.271% | +0.032 pp | +0.023 pp | +29.5% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.